In the AD pathway, the up-regulation of Snca and the resulting accumulation of Aβ may activate caspases, facilitate tau hyper-phosphorylation, disrupting mitochondria function and triggering calcium dysfunction. Here, SNCA is linked to Alzheimer disease.